TABLE 1.
Summary of metabolic studies with Irx3 or Irx5 mutant mice.
Mouse model | Transgenic system | Target tissue | Metabolic phenotype | References | ||
Irx3 tLZ/tLZ | Part of exon 1 replaced by tauLacZ | Germ-line | Lean (Runty) | Energy expenditure ↑ Adipose beging ↑ | *Food intake↓ | Smemo et al., 2014 |
Irx3 Δ/Δ | CRISPR/Cas9 editing of exon 2 | Germ-line | Lean | Adipose beging ↑ | Sucrose preference↓ | Sobreira et al., 2021 |
Irx5 eGFP/eGFP | Part of exon 1 replaced by eGFP | Germ-line | Lean (Runty) | Energy expenditure ↑ Adipose beging ↑ | *Food intake↓ | Bjune et al., 2018; Son et al., 2021b |
Irx3+Irx5+ /Irx3 del Irx5 eGFP | Deletion of exons 2 to 4 of Irx3 in Irx5eGFP line | Germ-line | Lean | Energy expenditure ↑ Adipose beging ↑ | Food intake↓ Hypothalamic leptin response ↑ |
Son et al., 2021a |
Irx5 Δ/+ | CRISPR/Cas9 editing of exon 2 | Germ-line | Lean | Adipose beging ↑ | N/A | Sobreira et al., 2021 |
Ins2-Cre;Rosa26EnR–Irx3/+ | Expression of dominant-negative form of IRX3 | Hypothalamus | Lean | Energy expenditure ↑ Adipose beging ↑ | *Food intake↓ | Smemo et al., 2014; Son et al., 2021b |
Ins2-Cre;Irx3F/F | Flanking exons 2 to 4 with loxP sites | Hypothalamus | Lean | No difference in energy expenditure | Food intake↓ Hypothalamic leptin response ↑ |
Son et al., 2021a |
Deletion of Irx3 in macrophage, or expression of a “dominant-negative form of mouse IRX3” in adipose tissue (aP2-Cre;Rosa26EnR–Irx3/+) or “human IRX3” in brown adipose tissue (Ucp1-Cre;Rosa26hIRX3/+) leads to a lean phenotype with adipose beiging and elevated energy expenditure (Smemo et al., 2014; Yao et al., 2021; Zhang et al., 2021).
*Though difference in daily food intake is not significantly different, these mutants show reduced amounts of food intake from long-term feeding analysis over life time.